Cargando…
Exploration of the breast ductal carcinoma in situ signature and its prognostic implications
Following the implementation of breast screening programs, the occurrence of ductal carcinoma in situ (DCIS) as an early type of neoplasia has increased. Although the prognosis is promising, 20%–50% of DCIS patients will progress to invasive ductal carcinoma (IDC) if not treated. It is essential to...
Autores principales: | Zhang, Jiao, Lin, Hui, Hou, Lei, Xiao, Hui, Gong, Xilong, Guo, Xuhui, Cao, Xuchen, Liu, Zhenzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939111/ https://www.ncbi.nlm.nih.gov/pubmed/35880695 http://dx.doi.org/10.1002/cam4.5071 |
Ejemplares similares
-
Multi-protein spatial signatures in ductal carcinoma in situ (DCIS) of breast
por: Badve, Sunil S., et al.
Publicado: (2021) -
The prognostic significance of immune microenvironment in breast ductal carcinoma in situ
por: Toss, Michael S., et al.
Publicado: (2020) -
Ductal Carcinoma In Situ of the Breast
por: Lee, Richard J., et al.
Publicado: (2012) -
Breast Ductal Carcinoma In Situ
por: Sacchini, Virgilio, et al.
Publicado: (2012) -
Ductal carcinoma in situ of the breast: morphological and molecular features implicated in progression
por: Carraro, Dirce M., et al.
Publicado: (2014)